Simon Gritsch (@gritschsimon) 's Twitter Profile
Simon Gritsch

@gritschsimon

Physician scientist interested in brain cancer biology. Research Fellow @MGHPathology. Incoming resident @HarvardNeuroMDs.

ID: 1205146068779855872

calendar_today12-12-2019 15:23:16

14 Tweet

65 Followers

104 Following

Mario Suva (@mariosuva) 's Twitter Profile Photo

The 5th edition of the WHO classification of CNS tumors is online today! Great timing with SNO 2021 meeting! tumourclassification.iarc.who.int/welcome/

The 5th edition of the WHO classification of CNS tumors is online today! Great timing with <a href="/NeuroOnc/">SNO</a> 2021 meeting! tumourclassification.iarc.who.int/welcome/
Mario Suva (@mariosuva) 's Twitter Profile Photo

Thrilled to share our preprint by Avishay Spitzer, MD, PhD 🎗️🧡, Simon Gritsch, a close collaboration with Tirosh Lab, Daniel Cahill and Keith Ligon, demonstrating that mutant-IDH inhibitors (mIDHi) act as  differentiation therapy in Oligodendroglioma (OG). medrxiv.org/cgi/content/sh…

Humsa Venkatesh (@humsav) 's Twitter Profile Photo

Excited for the next speaker in our BWH/Stanford Cancer Neuroscience Seminar Series! Dr. Frank Winkler will be providing his groundbreaking insights on Malignant Networks in the Brain. Register here: tinyurl.com/2pkcrcv4

Excited for the next speaker in our BWH/Stanford Cancer Neuroscience Seminar Series! Dr. Frank Winkler will be providing his groundbreaking insights on Malignant Networks in the Brain. Register here: tinyurl.com/2pkcrcv4
Cell (@cellcellpress) 's Twitter Profile Photo

Now online! Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy! #ScienceTwitter #CancerResearch bit.ly/3uwzL9n

Now online! Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy!
#ScienceTwitter #CancerResearch
bit.ly/3uwzL9n
NEJM (@nejm) 's Twitter Profile Photo

Late breaking at #ASCO23: Mutations in isocitrate dehydrogenase 1 or 2 are common in low-grade glioma. The IDH inhibitor vorasidenib improved progression-free survival as compared with placebo. Full results of the INDIGO trial: nej.md/3N8N5dU

Keith Ligon (@keithligon5) 's Twitter Profile Photo

Out today Cancer Cell from our teams: IDH inhibitors (like #Vorasidenib) induce differentiation in samples from treated #oligodendroglioma patients & NOTCH1 mutations may aid resistance. Seminal work by 1stauthors Avishay Spitzer, MD, PhD 🎗️🧡 Simon Gritsch Masashi Nomura authors.elsevier.com/a/1it88_Ywcvn8…

Out today <a href="/Cancer_Cell/">Cancer Cell</a> from our teams: IDH inhibitors (like #Vorasidenib) induce differentiation in samples from treated #oligodendroglioma patients &amp; NOTCH1 mutations may aid resistance. Seminal work by 1stauthors <a href="/AvishaySpitzer/">Avishay Spitzer, MD, PhD 🎗️🧡</a> <a href="/GritschSimon/">Simon Gritsch</a> <a href="/M_Nomura/">Masashi Nomura</a> authors.elsevier.com/a/1it88_Ywcvn8…
Tirosh Lab (@tiroshlab) 's Twitter Profile Photo

11/ Lastly, a highly recommended preview to our study beautifully written by Skylar Giacobetti and Howard Fine. x.com/Cancer_Cell/st…

David Gritsch, MD, PhD (@gritschdavid) 's Twitter Profile Photo

Excited to share our latest review in Trends in Molecular Medicine on the molecular evolution of CNS metastasis and its therapeutic implications! #CNSMetastasis #CancerResearch #PrecisionMedicine secure-web.cisco.com/1fdEIB_bPvgazc…

Mass General Brigham/HMS Neurology Residency (@harvardneuromds) 's Twitter Profile Photo

As the year winds down, we are excited to announce where our current PGY4s/NM3 will be continuing their post-residency journey! #NMatch2025 #Match2025 #neurology

As the year winds down, we are excited to announce where our current PGY4s/NM3 will be continuing their post-residency journey! #NMatch2025 #Match2025 #neurology